维普中文期刊产品整合服务
105篇 您的检索式:作者名="Christodoulos"
    题名 作者 年代 出处 被引量
1Evolution and advances in laparoscopic ventral and incisional hernia repair显示文摘Primary ventral hernias and ventral incisional hernias have been a challenge for surgeons throughout the ages. In the current era, incisional hernias have increased in prevalence due to the very high number of laparotomies performed in the 20 th century. Even though minimally invasive surgery and hernia repair have evolved rapidly, general surgeons have yet to develop the ideal, standardized method that adequately decreases common postoperative complications, such as wound failure, hernia recurrence and pain. The evolution of laparoscopy and ventral hernia repair will be reviewed, from the rectoscopy of the 4th century to the advent of laparoscopy, from suture repair to the evolution of mesh reinforcement. The nuances of minimally invasive ventral and incisional hernia repair will be summarized, from preoperative considerations to variations in intraoperative practice. New techniques have become increasingly popular, such as primary defect closure, retrorectus mesh placement, and concomitant component separation. The advent of robotics has made some of these repairs more feasible, but only time and well-designed clinical studies will tell if this will be a durable modality for ventral and incisional hernia repair.Alan L Vorst Christodoulos Kaoutzanis Alfredo M Carbonell Michael G Franz 2015World Journal of Gastrointestinal Surgery2015,7,11:10
2From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I显示文摘Morteza Naghavi Peter Libby Erling Falk S. Ward Casscells Silvio Litovsky John Rumberger Juan Jose Badimon Christodoulos Stefanadis Pedro Moreno Gerard Pasterkamp Zahi Fayad Peter H. Stone Sergio Waxman Paolo Raggi Mohammad Madjid Alireza Zarrabi Allen Bu 2003Circulation: Journal of the American Heart Association2003,,14:6
3浮萍生物质灰分的特性分析显示文摘利用低温成灰的方法对两种浮萍(紫萍和青萍)进行灰化,测定灰分含量,通过SEM/EDS分析、X射线衍射分析和TGA/DSC分析实验对两种灰分的形貌、成分、热活动等进行对比研究。结果显示:浮萍灰分中碱金属、碱土金属和氯含量高,硅含量低。灰分中KCl含量大,在温度升高时挥发量大,灰分的积灰结渣倾向严重。对于两种浮萍而言,紫萍的积灰结渣倾向重于青萍。这些结果表明在浮萍生物质燃烧和气化利用中应重视碱金属挥发和熔化所带来的积灰结渣问题。张志坚 齐泮仑 何皓 肖炘 曹宏斌 李杰 马炯 Christodoulos A. Floudas 李庆峰 2015太阳能学报2015,36,5:4
4Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness显示文摘Charalambos Vlachopoulos Konstantinos Aznaouridis Christodoulos Stefanadis 2010Journal of the American College of Cardiology2010,,13:3
5From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II显示文摘Morteza Naghavi Peter Libby Erling Falk S. Ward Casscells Silvio Litovsky John Rumberger Juan Jose Badimon Christodoulos Stefanadis Pedro Moreno Gerard Pasterkamp Zahi Fayad Peter H. Stone Sergio Waxman Paolo Raggi Mohammad Madjid Alireza Zarrabi Allen Bu 2003Circulation: Journal of the American Heart Association2003,,15:3
6Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction显示文摘Dimitris Tousoulis Charalambos Antoniades Erini Bosinakou Maria Kotsopoulou Costas Tsoufis Kyriakoula Marinou Marietta Charakida Elli Stefanadi Manolis Vavuranakis George Latsios Christodoulos Stefanadis 2006International Journal of Cardiology2006,,2:2
7Coronary artery disease in women:From the yentl syndrome to contemporary treatment显示文摘In recent years attention has been raised to the fact of increased morbidity and mortality between women who suffer from coronary disease. The identification of the so called Yentl Syndrome has emerged the deeper investigation of the true incidence of coronary disease in women and its outcomes. In this review an effort has been undertaken to understand the interaction of coronary disease and female gender after the implementation of newer therapeutic interventional and pharmaceutics' approaches of the modern era.Sofia Vaina Anastasios Milkas Christina Crysohoou Christodoulos Stefanadis 2015World Journal of Cardiology2015,7,1:2
8生物标记,勃起功能障碍和心血管风险预测:不断发展的新观点显示文摘许多循环和影像学标记与心血管风险密切相关。勃起功能障碍(ED)生物标记能进一步优化治疗方案。有证据表明对于没有动脉粥样硬化临床表现的ED患者,生物标记能提高风险预测能力。对ED人群的更好鉴别需要进一步的风险分层和随机试验来验证生物标记预测心血管疾病风险的能力,以达到生物标记的疾病预防作用。Charalambos Vlachopoulos Nikolaos Ioakeimidis Christodoulos Stefanadis 2015Asian Journal of Andrology2015,17,1:2
9Primary Prevention of Sudden Cardiac Death in a Nonischemic Dilated Cardiomyopathy Population: Reappraisal of the Role of Programmed Ventricular Stimulation显示文摘Konstantinos A. Gatzoulis Apostolos-Ilias Vouliotis Dimitris Tsiachris Maria Salourou Stefanos Archontakis Polychronis Dilaveris Theodoros Gialernios Petros Arsenos Georgios Karystinos Skevos Sideris Ioannis Kallikazaros Christodoulos Stefanadis 2013Circulation: Arrhythmia and Electrophysiology2013,,3:2
10Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors:A meta-analysis of cardiovascular outcome trials显示文摘BACKGROUND Dipeptidyl peptidase-4(DPP-4)inhibitors are a generally safe and well tolerated antidiabetic drug class with proven efficacy in type 2 diabetes mellitus(T2DM).Recently,a series of large,randomized controlled trials(RCTs)addressing cardiovascular outcomes with DPP-4 inhibitors have been published.AIM To pool data from the aforementioned trials concerning the impact of DPP-4 inhibitors on surrogate cardiovascular efficacy outcomes and on major cardiac arrhythmias.METHODS We searched PubMed and grey literature sources for all published RCTs assessing cardiovascular outcomes with DPP-4 inhibitors compared to placebo until October 2020.We extracted data concerning the following“hard”efficacy outcomes:fatal and non-fatal myocardial infarction,fatal and non-fatal stroke,hospitalization for heart failure,hospitalization for unstable angina,hospitalization for coronary revascularization and cardiovascular death.We also extracted data regarding the risk for major cardiac arrhythmias,such as atrial fibrillation,atrial flutter,ventricular fibrillation and ventricular tachycardia.RESULTS We pooled data from 6 trials in a total of 52520 patients with T2DM assigned either to DPP-4 inhibitor or placebo.DPP-4 inhibitors compared to placebo led to a non-significant increase in the risk for fatal and non-fatal myocardial infarction[risk ratio(RR)=1.02,95%CI:0.94-1.11,I2=0%],hospitalization for heart failure(RR=1.09,95%CI:0.92-1.29,I2=65%)and cardiovascular death(RR=1.02,95%CI:0.93-1.11,I2=0%).DPP-4 inhibitors resulted in a non-significant decrease in the risk for fatal and non-fatal stroke(RR=0.96,95%CI:0.85-1.08,I2=0%)and coronary revascularization(RR=0.99,95%CI:0.90-1.09,I2=0%),Finally,DPP-4 inhibitors demonstrated a neutral effect on the risk for hospitalization due to unstable angina(RR=1.00,95%CI:0.85-1.18,I2=0%).As far as cardiac arrhythmias are concerned,DPP-4 inhibitors did not significantly affect the risk for atrial fibrillation(RR=0.95,95%CI:0.78-1.17,I2=0%),while they were associated with a significant increase in the risk for atrial flutter,equal to 52%(RR=1.52,95%CI:1.03-2.24,I2=0%).DPP-4 inhibitors did not have a significant impact on the risk for any of the rest assessed cardiac arrhythmias.CONCLUSION DPP-4 inhibitors do not seem to confer any significant cardiovascular benefit for patients with T2DM,while they do not seem to be associated with a significant risk for any major cardiac arrhythmias,except for atrial flutter.Therefore,this drug class should not be the treatment of choice for patients with established cardiovascular disease or multiple risk factors,except for those cases when newer antidiabetics(glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors)are not tolerated,contraindicated or not affordable for the patient.Dimitrios Ioannis Patoulias Aristi Boulmpou Eleftherios Teperikidis Alexandra Katsimardou Fotios Siskos Michael Doumas Christodoulos E Papadopoulos Vassilios Vassilikos 2021World Journal of Cardiology2021,13,10:2
11Global optimization in design and control of chemical process systems显示文摘Christodoulos A Floudas 2000J Process Control2000,10,23:2
12Cigarette smoking and myocardial infarction in young men and women: A case-control study显示文摘Demosthenes B. Panagiotakos Loukianos S. Rallidis Christos Pitsavos Christodoulos Stefanadis Dimitrios Kremastinos 2006International Journal of Cardiology2006,,3:2
13Unsupervided Pattern Recognition for the Classfication of EMG Signals显示文摘Christodoulos IC Constantinos SP 1999IEEE Transactions on Biomedical Engineering1999,46,2:1
14Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches显示文摘Dimitris Tousoulis Chryssa Simopoulou Nikos Papageorgiou Evangelos Oikonomou George Hatzis Gerasimos Siasos Eleftherios Tsiamis Christodoulos Stefanadis 2014Pharmacology and Therapeutics2014,,3:1
15Combination antiangiogenesis therapy with marimastat, eaptopril and fragmin in patients with advanced cancer 显示文摘Jones PH Christodoulos K Dobbs N 2004Br J Cancer2004,91,1:1
16Heat production ofatherosclerotic plaques and inflammation assessed by the acute phaseproteins in acute coronary syndromes显示文摘Christodoulos S Leonidas D John D 2000J Mol Cell Cardio J2000,32,:1
17Linear array geometry synthesis with minimum sidelobe level and null control using particle swarm optimization显示文摘Khodier M M Christodoulo u C G 0,,08:1
18Heat production of atheroselerotie plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes显示文摘Christodoulos S Leonidas D John D 2000J Mol Cell Cardio J2000,32,:1
19Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis显示文摘Charalambos V Konstantinos A Christodoulos S 2010J Am Coll Cardiol2010,559,13:1
20Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: The impact of inflammatory process and oxidative stress显示文摘Dimitris Tousoulis Ioannis Andreou Marinos Tsiatas Antigoni Miliou Costas Tentolouris Gerasimos Siasos Nikos Papageorgiou Christos A. Papadimitriou Meletios-Athanasios Dimopoulos Christodoulos Stefanadis 2010Atherosclerosis2010,,1:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费